PET in esophageal cancer

PET/CT: Essentials for Clinical Practice

Volumn , Issue , 2007, Pages 143-157

  O'connell, Martin J ^a   Workman Jr , Ronald B ^b   Coleman, R Edward ^c,d  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Department of Radiology ^*  (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891976176     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-38335-4_9     Document Type: Chapter

References (22)

1. What are the key statistics about cancer of the esophagus? American Cancer Society (www.cancer.org); 2005 Accessed August 2005.
2. Vermund H, Pories WJ, Hillard J, Wiley AL, Youngblood R. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer. Acta Oncol 2001;40:558-565.
3. Flamen P, Mortelmans L. Gastro-esophageal cancer. In: Oehr P, Biersack HJ, Coleman E, editors. PET and PET-CT in Oncology. Berlin: Springer; 2003;18:187-202.
4. Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with FDG PET. AJR Am J Roentgenol 1997;168:417-424.
5. Luketich JD, Friedman DM, Weigel TL, et al. Evaluation of distant metastasis in esophageal cancer. 100 consecutive PET scans. Ann Thorac Surg 1999;68:1135-1137.
6. Heeren PA, Jager PL, Bongaerts F, Van Dullemen H, Sluiter W, Plukker JT. Detection of distant metastasis in esophageal cancer with F-18 FDG PET. J Nucl Med 2004;45:980-987.
7. Fukunaga T, Okazumi S, Koide Y, et al. Evaluation of esophageal cancers using F18-FDG PET. J Nucl Med 1998;39:1002-1007.
8. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for carcinoma of the thoracic esophagus. Ann Surg 1994;220:364-373.
9. McLoud TC, Bourjoin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by comparison with lymph node mapping and sampling. Radiology 1992;182:319-323.
10. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-3210.
11. Fickling WE, Wallace MB. Endoscopic ultrasound and upper gastrointestinal disorders. J Clin Gastroenterol 2003;36:103-110.
12. Rasanen J V, Sihvo EI, Knuuti MJ, et al. Prospective analysis of the accuracy of positron emission tomography, computed tomography and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the gastroesophageal junction. Ann Surg Oncol 2003;10:954-960.
13. Wren SM, Stijins P, Srinivas S. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 2002;137:1001-1006.
14. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of respectability. Radiology 1995;195:327-332.
15. Lerut T, Flamen P, Ectors N, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction. A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 2000;232:743-752.
16. Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 2001;71:290-294.
17. Dehdashti F, Siegel BA. Neoplasms of the esophagus and stomach. Semin Nucl Med 2004;34(3):198-208.
18. Weber WA, Ott K, Becker K, et al. Predication of response to preoperative chemotherapy in adenocarcinomas of esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-3065.
19. Brucher BL, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001;233:300-309.
20. Flamen P, Van Cutsem E, Lerut A, et al. Positron emission tomography for assessment of response to induction radiochemotherapy in locally advanced esophageal carcinoma. Ann Oncol 2002;13:361-368.
21. Flamen P, Lerut A, Van Cutsem E, et al. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 2000;120:1085-1092.
22. Yeung HW, Macapinlac HA, Mazumdar M, Bains M, Finn RD, Larson SM. FDG-PET in esophageal cancer - incremental value over computed tomography. Clin Positron Imaging 1999;2(5):255-260.